Starry(SH:603520) Xin Lang Cai Jing·2026-01-21 02:39Group 1 - The stock of Zhejiang Sitaili Pharmaceutical Co., Ltd. increased by 5.01% on January 21, reaching a price of 11.11 CNY per share, with a trading volume of 150 million CNY and a turnover rate of 3.14%, resulting in a total market capitalization of 4.871 billion CNY [1] - The company, established on September 15, 1997, and listed on March 9, 2016, specializes in the production and sales of non-ionic iodine contrast agents and quinolone raw materials, with the main business revenue composition being 79.73% from contrast agents, 10.19% from other supplementary products, 6.16% from other sources, 2.41% from CMO/CDMO, and 1.52% from quinolone series [1] Group 2 - The Noan Theme Select Mixed Fund (320012) holds 720,100 shares of Sitaili, representing 4.53% of the fund's net value, making it the tenth largest holding. The estimated floating profit for today is approximately 381,600 CNY [2] - The Noan Theme Select Mixed Fund was established on September 15, 2010, with a current size of 173 million CNY. Year-to-date returns are 15.8%, ranking 225 out of 8,844 in its category, while the one-year return is 43.35%, ranking 2,504 out of 8,091. Since inception, the fund has achieved a return of 257.08% [2] Group 3 - The fund manager of the Noan Theme Select Mixed Fund is Luo Chunlei, who has been in the position for 10 years and 121 days. The total asset size of the fund is 173 million CNY, with the best return during the tenure being 130.62% and the worst return being 2.88% [3]